Anti-obesity drug is entitled to additional benefits on the cardiometabolic risk factors, asked

Bulletin 2007, 45: 41-3 DTB.

Pages: 1 [2] 


Input your comment:
Name:
Site url: http://
Message:
Enter today's date, 2 digits
(spam protection):